RAPS Sponsored Webcast: Navigating the UK Drug Approval Landscape Post-Brexit
The UK Medicines and Healthcare products Regulatory Agency (MHRA) gained independence from the EU regulatory system in 2021, allowing it to make decisions about the approval of medicines in the UK without being influenced by the EU, except for in Northern Ireland, which is covered by the Protocol on Ireland/Northern Ireland. Throughout its the transition … Continued
https://www.certara.com/on-demand-webinar/raps-sponsored-webcast-navigating-the-uk-drug-approval-landscape-post-brexit/